Guangzhou Baiyunshan Pharmaceutical Holdings Company(DE:GU5)
€1.430.00 (-2.05%)
DE:GU5
Guangzhou Baiyunshan Pharmaceutical Holdings Company Revenue
€1.43
At close:0.00 (-2.05%)
Guangzhou Baiyunshan Pharmaceutical Holdings Company (GU5) Revenue
1 Followers
Guangzhou Baiyunshan Pharmaceutical Holdings Company Revenue
Guangzhou Baiyunshan Pharmaceutical Holdings Company had a revenue of 19.98B in the quarter ending Sep 30, 2026, with 6.67%. This bring the company's revenue in the last twelve months to 77.81B, Increased 0.28%. In the fiscal year ending Dec 31, 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 77.66B with 3.55% growth.
- Revenue (ttm)
- 77.81B
- Revenue Growth
- 0.35%
- P/S Ratio
- 0.05
- Revenue/Employee
- EUR 2,870,093
- Employees
- 27,057
- Market Cap
- EUR 4.08B
Revenue Chart
Guangzhou Baiyunshan Pharmaceutical Holdings Company Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.66B | 2.66B | 3.55% |
| Dec 31, 2024 | 74.99B | -522.58M | -0.69% |
| Dec 31, 2023 | 75.52B | 4.73B | 6.68% |
| Dec 31, 2022 | 70.79B | 1.77B | 2.57% |
| Dec 31, 2021 | 69.01B | 7.34B | 11.90% |
| Dec 31, 2020 | 61.67B | -3.28B | -5.05% |
| Dec 31, 2019 | 64.95B | 22.72B | 53.79% |
| Dec 31, 2018 | 42.23B | 21.28B | 101.55% |
| Dec 31, 2017 | 20.95B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.